Emmanuel J Favaloro/LinkedIn
Jun 19, 2026, 22:46
Emmanuel J. Favaloro: Machine Learning Driving Innovation in Thrombosis and Hemostasis
Emmanuel J. Favaloro, Lead Scientist at the Sydney Centres for Thrombosis and Haemostasis at Westmead Hospital, Editor in Chief of Seminars in Thrombosis and Hemostasis, shared a post on LinkedIn about a recent article Michael Nagler et al, published in Seminars in Thrombosis and Hemostasis, adding:
“Making Machine Learning Clinically Useful in Thrombosis and Hemostasis.
Just uploaded to Seminars in cand Hemostasis.
Free to download.
Enjoy!”
Title: Making Machine Learning Clinically Useful in Thromb
Authors: Michael Nagler, Henning Nilius, Janna Hastings, Christos Nakas
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 29, 2026, 19:00Caitlin Raymond: Can Artificial Blood Solve Blood Supply Shortages?
-
Sep 29, 2026, 18:51Chaza Alaji: Dyslipidemia, Thrombosis and the DIC Diagnostic Trap
-
Sep 29, 2026, 17:31Rajnikant Patel: Bridging Ayurvedic Concepts and Modern Toxin-Mediated Disease
-
Sep 29, 2026, 17:13Nicholas Lang։ A Meaningful Case of Immune Thrombocytopenia
-
Sep 29, 2026, 16:55Ayatullah Gamal Wahab: When the CBC Lies
-
Sep 29, 2026, 16:35Jonathan Douxfils: Navigating the VTE Risk Continuum in Reproductive Medicine
-
Sep 29, 2026, 16:35Chaima Rajeh: Types of Anemia and Their Laboratory Features
-
Sep 29, 2026, 16:27Scott Isaacs: How GLP-1 RAs Target Systemic Inflammation to Drive Cardio, Autoimmune, and Gut Health
-
Sep 29, 2026, 16:21Yitshak Kreiss: From Treating Patients to Defining the Standard of Knowledge